Sofosbuvir/Ombitasvir/Paritaprevir/ Ritonavir and Ribavirin for Hepatitis C Virus Genotype 4 Patients

Exclusion Criteria

• •liver disease of non-HCV GT4 etiology, coinfection with hepatitis B or HIV
• •poorly controlled diabetes (HbA1C \> 8)
• •participants, hepatocellular carcinoma, a history of extrahepatic malignancy in the 5 years prior to the study
• •renal failure
• •evidence of hepatic decompensation
• •blood picture abnormalities such as anemia (hemoglobin concentration of \< 10 g/dL)
• •thrombocytopenia (platelets count \< 50,000 cells/mm3).
• •major severe illness such as congestive heart failure and respiratory failure.